Current Edition

New Understanding and New Tools to Improve the Effectiveness of Oncology Clinical Development (and Potentially Reduce Drug Costs)

High-priced prescription drugs have been making headlines for years, but soaring insurance premiums have put drug costs back in the spotlight. Ryan Mcguire, Rochelle gagg and adam Bianchi at Cutting Edge Info discuss how executives from nearly every pharmaceutical company consistently cite the same three justifications for high costs.